Updated:
Nobelpharma
Nobelpharma is a pharmaceutical company based in Tokyo, Japan. It develops and delivers drugs and medical devices for diseases affecting small patient...
Nobelpharma
Nobelpharma is a pharmaceutical company based in Tokyo, Japan. It develops and delivers drugs and medical devices for diseases affecting small patient populations. Nobelpharma's portfolio includes a range of products, with a focus on expanding its reach to the United States and Europe.
General information
Firm type
Corporate Investor
Year founded
2003
AUM
Undisclosed
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
1-17-24, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan
Additional offices
Bethesda, MD, USA · Dusseldorf, Germany · Taizhou, Jiangsu, China
Principals
Jin Shiomura
Managing Director and CEO
Sector focus
Frequently asked questions
What therapeutic areas does Nobelpharma focus on?
Nobelpharma concentrates on rare and intractable diseases with high unmet medical need. Its portfolio spans oncology, immunology, neurology, and metabolic disorders. The pipeline includes products for pediatric hypophosphatasia and non-muscle-invasive bladder cancer (per the firm, 2023).
Who are the key strategic partners behind Nobelpharma?
MEDIPAL HOLDINGS CORPORATION is a major shareholder providing distribution and logistics support across Japan. Inabata & Co., Ltd. has been a financial supporter and major shareholder since Nobelpharma's founding in 2003. Hisanaga & Co., Ltd. provides business management services to the group.
Is Nobelpharma strictly a Japanese company or does it have global operations?
Nobelpharma maintains a global footprint beyond its Tokyo headquarters. It operates a US office in Bethesda, Maryland, a European office in Dusseldorf, Germany, and a manufacturing and development subsidiary in Taizhou, Jiangsu, China. The company sources many of its drug candidates through international licensing deals.
How does Nobelpharma acquire its drug pipeline?
The firm primarily in-licenses orphan drug candidates from Western biotech and pharmaceutical companies, then conducts clinical development and regulatory work tailored for Asian markets. It also engages in some internal R&D. Notable partnerships include Alexion (Strensiq) and Ferring Pharmaceuticals (Adstiladrin).
What philanthropic activities is Nobelpharma involved in?
Nobelpharma supports the GHIT Fund, a public-private partnership advancing global health technologies for neglected diseases, and the SickKids Foundation, a Canadian institution focused on pediatric healthcare and research. These align with the company's mission to address unmet medical needs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: